RENOVITE® Platform Development
Tissue Regeneration (Orthopedic focus)
Pre-clinicalActive
Key Facts
Indication
Tissue Regeneration (Orthopedic focus)
Phase
Pre-clinical
Status
Active
Company
About Renovos Biologics
Renovos Biologics is a private, preclinical-stage biotech company commercializing world-class research from the University of Southampton. Its core asset is the RENOVITE® platform, a synthetic nanoclay gel designed as an injectable scaffold to localize and retain biologics and cells for targeted tissue regeneration, primarily in orthopedic applications. The company is pre-revenue and appears to be seeking investment and partnerships to advance its platform and pipeline programs. Leadership combines deep academic expertise in skeletal stem cells and biomaterials with entrepreneurial business development.
View full company profile